Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Wednesday, April 1, 2015

Canada: Province covers cost of new hepatitis C drugs

The Saskatchewan government says it will now provide new drug coverage for hepatitis C -- a viral disease that affects the liver.

Health Minister Dustin Duncan says the new drugs, Harvoni and Sovaldi, are better tolerated by patients than other therapies.

The drugs are said to cure 90 to 98 per cent of patients in as little as eight to 12 weeks.

Read more...

No comments:

Post a Comment